In vivo evaluation of NM441, a new thiazeto-quinoline derivative.

NM441 is a lipophilic prodrug of a new thiazeto-quinoline carboxylic acid derivative NM394, and when it is administered orally it is readily absorbed and hydrolyzed to its parent compound. After oral administration of NM441 at a dose of 20 mg/kg to dogs, the peak concentration of NM394 in plasma was...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Ozaki, M, Matsuda, M, Tomii, Y, Kimura, K, Segawa, J, Kitano, M, Kise, M, Shibata, K, Otsuki, M, Nishino, T
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1991
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245419/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1667252/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.12.2496
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!